Application of Fragment Screening by X-ray Crystallography to the Discovery of Aminopyridines as Inhibitors of β-Secretase

Fragment-based lead discovery has been successfully applied to the aspartyl protease enzyme β-secretase (BACE-1). Fragment hits that contained an aminopyridine motif binding to the two catalytic aspartic acid residues in the active site of the enzyme were the chemical starting points. Structure-base...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 50; no. 6; pp. 1124 - 1132
Main Authors Congreve, Miles, Aharony, David, Albert, Jeffrey, Callaghan, Owen, Campbell, James, Carr, Robin A. E, Chessari, Gianni, Cowan, Suzanna, Edwards, Philip D, Frederickson, Martyn, McMenamin, Rachel, Murray, Christopher W, Patel, Sahil, Wallis, Nicola
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 22.03.2007
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Fragment-based lead discovery has been successfully applied to the aspartyl protease enzyme β-secretase (BACE-1). Fragment hits that contained an aminopyridine motif binding to the two catalytic aspartic acid residues in the active site of the enzyme were the chemical starting points. Structure-based design approaches have led to identification of low micromolar lead compounds that retain these interactions and additionally occupy adjacent hydrophobic pockets of the active site. These leads form two subseries, for which compounds 4 (IC50 = 25 μM) and 6c (IC50 = 24 μM) are representative. In the latter series, further optimization has led to 8a (IC50 = 690 nM).
Bibliography:Coordinates for the β-secretase complexes with compounds 3, 4, 6a, 6b, 7, and 8b have been deposited in the Protein Data Bank under accession codes 2OHP, 2OHQ, 2OHR, 2OHS, 2OHT and 2OHU, together with the corresponding structure factor files.
istex:E2CC004C9CF0A6E9C83F827BC3AE6BE6996AD3A7
ark:/67375/TPS-CR3WG3KL-G
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/jm061197u